Todas as fotos(1)

Documentos Principais

Visualizar Toda a Documentação

1604654

USP

Risperidone

Name: Risperidone
Brand: USP

United States Pharmacopeia (USP) Reference Standard

Sinônimo(s):

R 64,766

Faça loginpara ver os preços organizacionais e de contrato

Todas as fotos(1)

About This Item

Fórmula empírica (Notação de Hill):

C₂₃H₂₇FN₄O₂

Número CAS:

106266-06-2

Peso molecular:

410.48

Número MDL:

MFCD00274576

Código UNSPSC:

41116107

ID de substância PubChem:

329751052

NACRES:

NA.24

Produtos recomendados

Slide 1 of 3

1 of 3

Supelco

PHR1141

Ondansetron Hydrochloride

Supelco

PHR1000

Dextrose

Sigma-Aldrich

D122

Domperidone

grau

pharmaceutical primary standard

família API

risperidone

fabricante/nome comercial

USP

aplicação(ões)

pharmaceutical (small molecule)

Formato

neat

cadeia de caracteres SMILES

CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1

InChI

1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3

chave InChI

RAPZEAPATHNIPO-UHFFFAOYSA-N

Informações sobre genes

human ... DRD2(1813) , HTR2A(3356) , HTR2C(3358)

Procurando produtos similares? Visita Guia de comparação de produtos

Categorias relacionadas

Analytical Chemistry

Analytical Reference Materials for Pharma QC

Pharmacopeia & Metrological Institute Standards

Reference Materials

Descrição geral

Risperidone is a new central 5-hydroxytryptamine2 and dopamine D2 antagonist. It is used to treat agitation, aggression,and psychosis caused during demnetia. It is a neuroleptic drug. It is also an atypical antipsychotic drug which is used for treating schizophrenia.

Aplicação

It was used as reference standard during RP-UPLC analysis for determination of risperidone related compounds in Risperdal^® Consta (risperidone long-acting injection).

Nota de análise

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Outras notas

Sales restrictions may apply.

Informações legais

Risperdal is a registered trademark of Johnson & Johnson

produto relacionado

Nº do produto

Descrição

Preços

1604676

Y0001276

Risperidone impurity K, European Pharmacopoeia (EP) Reference Standard

1604756

BP1137

Risperidone, British Pharmacopoeia (BP) Reference Standard

BP1158

Risperidone impurity standard, British Pharmacopoeia (BP) Reference Standard

Pictogramas

GHS06

Palavra indicadora

Danger

Frases de perigo

H301

Declarações de precaução

P301 + P330 + P331 + P310

Classificações de perigo

Acute Tox. 3 Oral

Código de classe de armazenamento

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe de risco de água (WGK)

WGK 3

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Se precisar de ajuda, entre em contato Atendimento ao cliente

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Development and Validation of RP-UPLC Method for Determination of Related Substances in Risperdal? Consta?.

Chen, Cheng-Tung, Cheng-Wei Cheng, and Yu-Fang Hu.

Journal of Chromatography and Separation Techniques, 6.6, 1-1 (2015)

Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.

Yvonne Freund-Levi et al.

Dementia and geriatric cognitive disorders, 38(3-4), 234-244 (2014-06-28)

To examine the effects of galantamine and risperidone on agitation in patients with dementia. A total of 100 patients with dementia and neuropsychiatric symptoms (mean age ± SD: 78.6 ± 7.5 years; 67% female) were included in this 12-week, randomized

PCP-induced deficits in murine nest building activity: employment of an ethological rodent behavior to mimic negative-like symptoms of schizophrenia.

Christian Spang Pedersen et al.

Behavioural brain research, 273, 63-72 (2014-07-30)

Schizophrenia is a severe psychiatric disorder characterized by three symptom domains, positive (hallucinations, obsession), negative (social withdrawal, apathy, self-neglect) and cognitive (impairment in attention, memory and executive function). Whereas current medication ameliorates positive symptomatology, negative symptoms as well as cognitive

Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity.

Jérôme A J Becker et al.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 39(9), 2049-2060 (2014-03-13)

The etiology of Autism Spectrum Disorders (ASDs) remains largely unknown. Identifying vulnerability genes for autism represents a major challenge in the field and allows the development of animal models for translational research. Mice lacking the mu opioid receptor gene (Oprm1(-/-))

Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports.

W Victor R Vieweg et al.

Psychopharmacology, 228(4), 515-524 (2013-07-03)

A recent publication asserted that even low-dose risperidone may induce corrected QT (QTc) interval prolongation up to 500 ms without drug-induced IKr blockade. We seek to better understand the complexity of any link between risperidone-induced/associated QTc interval prolongation and torsade de

Exibir todos os documentos relacionados

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica